CORNELIS P. VAN DIJKE, M.D., Ph.D.; ROB J. HEYDENDAEL, M.D.; MARTIN J. DE KLEINE, M.D.
Hyperthyroidism during pregnancy generally is treated with antithyroid drugs. In their reviews of the literature, Burrow (1) and Cooper (2) have advised against the use of methimazole (thiamazole) in pregnant women with hyperthyroidism because two studies reported an association of the drug with congenital skin defects (aplasia cutis). In 1972, Milham and Elledge (3) briefly described the cases of 12 patients with congenital scalp defects and noted that in three cases, one of which included a pair of fraternal twins, the mother had taken methimazole during pregnancy. In 1975, Mujtaba and Burrow (4) reported data from their study on the
VAN DIJKE CP, HEYDENDAEL RJ, DE KLEINE MJ. Methimazole, Carbimazole, and Congenital Skin Defects. Ann Intern Med. 1987;106:60–61. doi: 10.7326/0003-4819-106-1-60
Download citation file:
Published: Ann Intern Med. 1987;106(1):60-61.
Endocrine and Metabolism, Thyroid Disorders.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use